We are delighted that we can make a small contribution to the important work of Dr. Scott Tighe, Technical Director at the Advanced …

Studies on cave bacteria have been a valuable research area in both geology and biology, providing insights into the evolution of antibiotic …

This research paper used the RNAssist’s vivoPHIX™ system to examine the intricacies of insect innate immunity. Sarah Merkling et al., aimed to …

Lanosterol is implicated in cataract formation – it has been proposed to help maintain lens transparency by inhibiting the formation of protein …

Dr Avila’s laboratory has used vivoPHIX™ to prepare human cataract crystallin proteins.  The study aimed to determine the expression of Lanosterol Synthase …

Nicholas Barry at the MIT Media Lab used vivoPHIX™ for preparing nematodes for fluorescence studies in work titled “Tools for connectomics in …

Mantke et al., demonstrated the use of virusPHIX-P9™ for stablising SARS-CoV-2 Antigen and use by 258 participants across 27 countries for Lateral flow …

Loop-mediated isothermal amplification (LAMP) has played a crucial role in filling global COVID-19 testing need.  ln this study, Moore et al., discuss the …

Kate Rawlinson at the Sanger Institute, Hinxton, UK used vivoPHIX™ to preserve RNA of the Schistosome parasite for a ‘circadian clock study’.  …

In this paper, Killip et al., (Public Health England) have used RNAssist’s virusPHIX™ reagents to demonstrate SARS-CoV-2 inactivation.  We were asked by the …

We are delighted to attend the 2nd Annual mRNA-Based Therapeutics Summit 24th-26th January 2023 in Berlin.  Following the successful development of vaccines …

In a further development of the collaboration between QCMD and RNAssist, QCMD will use the universal biological sample stabilization virusPHIX-P9™ as the …